Related Experiment Video

Updated: Mar 6, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.1K

A brief overview of influenza surveillance systems in Australia, 2015

Sheena G Sullivan1, Jane Raupach2, Lucinda J Franklin3

  • 1WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria.

Communicable Diseases Intelligence Quarterly Report
|March 10, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

16.2K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K

Related Experiment Videos

Last Updated: Mar 6, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

19.1K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

16.2K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

724
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
724
Vaccinations01:51

Vaccinations

52.8K
Overview
52.8K

Articles linked to this work by shared authors, journal, and citation graph.

Repeated influenza vaccination results in blunting rather than back-boosting of antibody responses against A(H3N2) antigens.

Research square·2026

CAUSAL-RSV: A study protocol for a causal mediation analysis of RSV vaccine effects in infants using real-world data.

medRxiv : the preprint server for health sciences·2026

A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic.

Vaccine·2026

Respiratory virus genomic epidemiology during post-pandemic re-emergence of influenza in Australia.

Virus evolution·2026

Natural direct effects of vaccines and post-vaccination behaviour.

Vaccine·2026

Risk of Severe Coronavirus Disease 2019 (COVID-19) in Pregnant and Postpartum Individuals After the Pandemic Emergency.

Obstetrics and gynecology·2026

National Notifiable Diseases Surveillance System, 1 October to 31 December 2017.

Communicable diseases intelligence quarterly report·2018

National Notifiable Diseases Surveillance System, 1 July to 30 September 2017.

Communicable diseases intelligence quarterly report·2018

National Notifiable Diseases Surveillance System, 1 April to 30 June 2017.

Communicable diseases intelligence quarterly report·2018

OzFoodNet quarterly report, 1 July to 30 September 2015.

Communicable diseases intelligence quarterly report·2018

OzFoodNet quarterly report, 1 April to 30 June 2015.

Communicable diseases intelligence quarterly report·2018

The Australian Sentinel Practices Research Network, 1 January to 31 March 2017.

Communicable diseases intelligence quarterly report·2018

Speech-based early depressive symptom screening using MAX-Net: a multi-scale autoencoder-augmented xLSTM framework.

Frontiers in psychiatry·2026

Artificial intelligence responses to bronchiectasis patients' questions: the AIR-BE study.

Therapeutic advances in respiratory disease·2026

Sense of agency promotes recognition memory: the role of self-referential processing.

International journal of psychophysiology : official journal of the International Organization of Psychophysiology·2026

AFTI: High-generalized facial template inversion under attribute guidance.

Neural networks : the official journal of the International Neural Network Society·2026

The effect of attentional loads on audiovisual integration: When spatial coincidence matters.

Attention, perception & psychophysics·2026

The AWARE (AI Use, Why, Attachment, Reality and Risk, and Effect on Functioning) Framework for Assessing Patients' Use of AI in Mental Health Care.

JMIR medical education·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us